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Objectives: Nogo-B is a protective factor in the vascu-
lar system, limiting the response to arterial injury. We
hypothesized that Nogo-B would diminish in thickened
vein grafts after exposure to arterial levels of pressure and
shear stress. We examined the expression of Nogo-B, as
well as its three receptors, Nogo-receptor (NgR), Nogo-B-
receptor (NgBR), and PirB (Paired immunoglobulin-like
receptor B), during mouse vein graft adaptation.
Methods:The intrathoracic inferior vena cava (IVC) of
C57Bl/6 (WT) or Nogo-A/B knockout (Nogo-KO) mice
was harvested and implanted as an interposition vein graft
into WT mice. Vein grafts were harvested and analyzed
after 3 weeks. mRNA transcript levels of Nogo-B, NgR,
NgBR, PirB and GAPDH were measured by qPCR. Im-
munohistology (IHC) and Western blotting were per-
formed using the antibodies: Nogo (N18: Santa Cruz),
Nogo-B (1761), F4/80 (AbD serotec).
Results: All vein grafts showed significant wall thick-
ening, with increased thickening in Nogo-KO compared to
WT grafts (0.125  .025 mm vs 0.043  0.003 mm, n 
4; p 0.05). InWT vein grafts, Nogo-B protein levels were
strongly increased compared to preimplantation IVC (IHC
density 6-fold, Western blot density 10-fold). Nogo-B
RNA transcripts were increased 2-fold in the vein graft
compared to IVC. Transcript levels of the NgR and NgBR
were unchanged in vein grafts compared to IVC, whereas
PirB transcript levels were increased approximately 20-fold
(n  3; p  0.05).
Conclusions: Nogo-B transcripts and protein, as well
as transcripts for its PirB receptor, were increased during
vein graft adaptation, suggesting that graft adaptation is
not a response to injury, but an adaptive remodeling re-
sponse. Nogo-B is a factor limiting this adaptive response,
and may signal via the PirB receptor. These results suggest
that Nogo-B signaling is a mechanism of vein graft adapta-
tion and might be a therapeutic target for human trials
targeting vein graft disease.
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Objectives:The 26S proteasome degrades themajority
of proteins in eukaryotic cells. The 11S proteasome activa-
tor (PA28) binds to the proteasome and increases its ability
to degrade small peptides. Expression of the PA28 subunits
(, , ) is induced by interferon- stimulation. Since
inflammation plays a role in the development of neointimal
hyperplasia, and since nitric oxide (NO) reduces neointimal
hyperplasia in animal models, we hypothesize that NO will
reduce the expression of PA28.
Methods: The carotid artery balloon injury model was
performed in 11-week-old male Sprague Dawley rats. Treat-
ment groups included injury or injuryPROLI/NO (20 mg).
PA28 subunit expression was assessed by Western blot
analysis on homogenized arteries excised 3 days after injury
(n  3/group) and by immunofluorescent staining of
carotid artery sections harvested 14 days after injury (n 
3/group). Contralateral arteries served as uninjured con-
trols.
Results: Following arterial injury, Western blot analy-
sis showed that expression of the PA28,  and  subunits
remained unchanged. However, after injury and treatment
with NO, expression of the PA28,  and  subunits
decreased substantially in the carotid artery lysates (1.9-,
2.3- and 3.4-fold, respectively). Immunofluorescence
staining of carotid artery sections following injury revealed
a slight increase in the expression of PA28 in the adven-
titia, perhaps due to multimeric PA28 binding the anti-
body more effectively. The expression of PA28 and 
following injury were relatively similar to control. NO
significantly decreased the expression of PA28 in the
media, whereas NOdecreased the expression of PA28 and
 throughout the neointima, media and adventitia.
Conclusions:We report that NOdecreased the expres-
sion of PA28 ,  and  following arterial injury in vivo.
Since the PA28 subunits are involved in the breakdown of
peptides during inflammation, PA28 inhibition may be one
mechanism by which NO inhibits neointimal hyperplasia.
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